SMN2 and proximal spinal muscular atrophy: Examples of other SMN2 inducers include the splice switching oligonucleotide Spinraza (nusinersen; [67–69]), which is the first FDA-approved SMA therapeutic, or the small molecule SMN2 exon 7 splicing modifier RG7800 [70–72].